BETASIL COMBINATION PRODUCT LOZENGES

Indications

• Digestive disorders
• Respiratory conditions
• Inflammation
• Antioxidant support
• Antimicrobial activity

Dosage

Children: Refer to established herbal guidelines or consult a healthcare professional for appropriate dosing.

Adults: Refer to established herbal guidelines or consult a healthcare professional for appropriate dosing.

Mechanism of action

The active compounds in Belerica, such as gallic acid and other tannins, exhibit a range of pharmacological effects. These compounds are thought to contribute to its antioxidant activity by scavenging free radicals, thereby protecting cells from oxidative stress. Additionally, Belerica may modulate inflammatory pathways and enhance mucosal health, supporting gastrointestinal and respiratory function.

Pharmacodynamics

Belerica's pharmacodynamics involve several mechanisms, including the modulation of enzymatic activities related to inflammation, enhancement of mucus production in the respiratory tract, and promotion of gastrointestinal motility. Its antioxidant properties help in reducing the burden of oxidative damage in various tissues, potentially lowering the risk of chronic diseases. The synergy among its active components may enhance its therapeutic effects.

Pharmacokinetics

The pharmacokinetics of Belerica are not well-characterized in clinical literature. However, it is generally understood that the bioactive compounds may undergo absorption in the gastrointestinal tract, followed by hepatic metabolism. The elimination half-life and specific metabolic pathways have not been extensively studied, limiting the understanding of how these compounds behave in the body. Further research is needed to elucidate these aspects.

Adverse effects

• Gastrointestinal disturbances
• Allergic reactions
• Hypoglycemia
• Nausea
• Diarrhea

Interactions

• May enhance the effects of antidiabetic medications
• Potential interaction with blood-thinning medications

Precautions

• Use with caution in patients with diabetes
• Monitor for potential allergic reactions
• Use in pregnancy only if clearly needed

Pregnancy

Limited data available, use with caution and only if necessary.

Breast-feeding

Consult a healthcare provider before use.

Storage

Store in a cool, dry place away from direct sunlight.

Formulations

• Dried fruit powder
• Capsules
• Extracts

Indications

• Inflammatory conditions
• Cancer prevention and treatment
• Antioxidant therapy
• Digestive disorders
• Cardiovascular health

Dosage

Children: Refer to the BNF for Children for appropriate pediatric dosing recommendations.

Adults: Refer to the BNF for specific dosing guidelines, as dosages can vary based on the formulation and clinical indication.

Mechanism of action

Curcumin acts as a scavenger of reactive oxygen species, including hydroxyl radicals and superoxide anions, and inhibits lipid peroxidation as well as peroxide-induced DNA damage. It exhibits potent anti-inflammatory and anti-carcinogenic effects by modulating various signaling molecules. Curcumin inhibits protein kinases, c-Jun/AP-1 activation, and cyclooxygenase (COX)-2 activity, impacting cellular signal transduction pathways related to growth and malignant transformation.

Pharmacodynamics

In experimental animal models, curcumin has demonstrated significant pharmacological effects, such as increasing bile flow and inhibiting inflammation and edema formation. It has been shown to decrease cell proliferation and promote apoptosis in cancer cells. Additionally, curcumin inhibits platelet aggregation induced by arachidonic acid, suggesting its role in cardiovascular health.

Pharmacokinetics

Curcumin's pharmacokinetics are characterized by low bioavailability due to rapid metabolism and systemic elimination. It undergoes extensive hepatic metabolism, leading to the production of several metabolites. The absorption of curcumin can be enhanced by co-administration with piperine. Oral bioavailability remains a challenge, which has led to the exploration of various formulations to improve its therapeutic efficacy.

Adverse effects

• Gastrointestinal disturbances
• Nausea
• Diarrhea
• Allergic reactions

Interactions

• May enhance the effects of anticoagulants
• Potential interaction with antidiabetic medications
• May interfere with the metabolism of certain drugs due to inhibition of cytochrome P450 enzymes

Precautions

• Use with caution in patients with gallbladder disease
• Monitor patients on anticoagulant therapy
• Caution in patients with diabetes due to potential hypoglycemic effects

Pregnancy

Safety during pregnancy has not been established, caution is advised.

Breast-feeding

Curcumin may be excreted in breast milk, caution is advised.

Storage

Store in a cool, dry place away from light.

Formulations

• Powder
• Capsules
• Tablets
• Liquid extracts

Indications

• Gastrointestinal disorders (e.g., peptic ulcers, dyspepsia)
• Respiratory conditions (e.g., cough, bronchitis)
• Inflammatory conditions (e.g., arthritis, dermatitis)
• Viral infections (e.g., hepatitis, herpes simplex)

Dosage

Children: Refer to established clinical guidelines for appropriate dosing, as no specific dose is provided.

Adults: Refer to established clinical guidelines for appropriate dosing, as no specific dose is provided.

Mechanism of action

Glycyrrhizin, the active compound in glabra, inhibits the enzyme 11β-hydroxysteroid dehydrogenase type 2, leading to increased cortisol levels in tissues. This mechanism helps to reduce inflammation and modulate immune responses. Additionally, glabra exhibits antiviral activity by inhibiting the replication of certain viruses, possibly through interference with viral proteins and host cell interactions.

Pharmacodynamics

The pharmacodynamic effects of glabra are primarily attributed to glycyrrhizin and flavonoids present in the plant. Its anti-inflammatory effects are mediated through the inhibition of pro-inflammatory cytokines and pathways such as NF-κB. The compound also has expectorant properties, aiding in the relief of cough and respiratory distress by promoting mucus secretion and reducing irritation in the airways.

Pharmacokinetics

Glycyrrhizin is absorbed in the gastrointestinal tract, and its bioavailability can be influenced by the presence of other food components. Once absorbed, it undergoes hepatic metabolism, with its metabolites excreted primarily through urine. The half-life of glycyrrhizin can vary but is generally several hours, necessitating multiple doses for sustained therapeutic effects. Chronic use may lead to accumulation and potential side effects such as hypertension and hypokalemia due to its mineralocorticoid-like effects.

Pregnancy

The safety of glabra during pregnancy has not been established. It is advisable to avoid its use unless clearly needed.

Breast-feeding

There is limited information on the excretion of glabra in human milk. Caution is advised when administering to breastfeeding mothers.

Storage

Store at room temperature, away from moisture and direct light. Keep out of reach of children.

Indications

• Adrenal insufficiency
• Chronic inflammatory conditions

Mechanism of action

Glycyrrhizin, the primary active component of Glycyrrhiza, exerts its effects primarily through inhibition of the enzyme 11β-hydroxysteroid dehydrogenase type 2 (11β-HSD2). This inhibition prevents the conversion of active cortisol to inactive cortisone, leading to increased cortisol levels. Elevated cortisol mimics the effects of aldosterone, resulting in sodium retention, potassium excretion, and increased blood pressure. Additionally, licorice has anti-inflammatory and antiviral properties attributed to its ability to modulate various immune pathways and inhibit viral replication.

Pharmacodynamics

The pharmacodynamic effects of Glycyrrhiza include anti-inflammatory, antiviral, and immunomodulatory activities. Glycyrrhizin has been shown to reduce inflammation by inhibiting the production of pro-inflammatory cytokines and mediators. Its potential antiviral properties are particularly noted in viral infections such as hepatitis C and COVID-19, where it may inhibit viral replication. Furthermore, its ability to enhance the effects of corticosteroids can be beneficial in treating conditions associated with adrenal insufficiency or chronic inflammation.

Pharmacokinetics

Glycyrrhizin is absorbed from the gastrointestinal tract, with peak plasma concentrations occurring within 1-2 hours after oral administration. It undergoes extensive metabolism in the liver, primarily through conjugation processes, leading to the formation of glycyrrhetic acid as a major metabolite. The elimination half-life of glycyrrhizin is approximately 6-8 hours. Glycyrrhiza components are excreted in urine predominantly as conjugated forms. Long-term use can lead to accumulation and potential side effects due to its mineralocorticoid-like effects.

Contra-indications

• Hypertension
• Hypokalemia
• Severe kidney disease
• Pregnancy (due to hormonal effects)

Adverse effects

• Hypertension
• Hypokalemia
• Edema
• Headaches
• Fatigue
• Muscle weakness
• Cardiac arrhythmias (with excessive use)

Interactions

• May enhance the effects of corticosteroids
• May increase the risk of hypokalemia with diuretics
• May interact with anticoagulants, increasing the risk of bleeding
• May affect the metabolism of drugs metabolized by CYP3A4

Precautions

• Use with caution in patients with cardiovascular disease
• Monitor blood pressure and potassium levels during prolonged use
• Not recommended for long-term use without medical supervision

Pregnancy

Glycyrrhiza should be avoided during pregnancy as it may cause hormonal effects that could affect fetal development.

Breast-feeding

Consult a healthcare provider before use while breastfeeding, as safety is not well established.

Storage

Store in a cool, dry place, away from direct sunlight and moisture.

Formulations

• Dried root
• Extracts (liquid and powdered)
• Teas
• Capsules

Indications

• Anxiety
• Insomnia
• Nutritional supplement
• Antioxidant support
• Immune system support

Dosage

Children: Refer to authoritative sources for specific dosing information.

Adults: Refer to authoritative sources for specific dosing information.

Mechanism of action

The mechanism of action of Longan is not fully elucidated, but it is believed to exert its effects through the modulation of neurotransmitters, particularly influencing serotonin and gamma-aminobutyric acid (GABA) pathways. The fruit is rich in antioxidants, which may contribute to its protective effects against oxidative stress.

Pharmacodynamics

Longan is known for its high content of vitamins, minerals, and antioxidants, including vitamin C, B vitamins, and polyphenols. These compounds may enhance immune function, promote nervous system health, and improve skin health. Its calming effects may be attributed to constituents that influence neurotransmitter activity.

Pharmacokinetics

The pharmacokinetics of Longan is not well-studied, but as a food source, it is likely to be absorbed through the gastrointestinal tract. The bioavailability of its active compounds may vary depending on preparation methods (fresh, dried, or processed). The metabolism and excretion pathways are not clearly defined in the literature.

Pregnancy

Insufficient data on the safety of longa during pregnancy. Consult a healthcare provider before use.

Breast-feeding

Insufficient data on the excretion of longa in human milk. Caution is advised when using during breastfeeding.

Storage

Store in a cool, dry place away from direct sunlight. Keep out of reach of children.

Indications

• Digestive issues
• Nausea
• Headaches
• Muscle pain
• Respiratory conditions such as cough and nasal congestion

Dosage

Children: Refer to specific formulations and product guidelines for pediatric dosing, as formulations may vary and should be used with caution in children.

Adults: Refer to specific formulations and product guidelines for dosing, as mentha is available in various forms including teas, extracts, and topical applications.

Mechanism of action

Mentha species contain essential oils, primarily menthol and menthone, which exert their effects through several mechanisms. Menthol acts as a competitive antagonist of the transient receptor potential cation channel subfamily M member 8 (TRPM8), which is involved in the sensation of cold. This interaction provides a cooling sensation and can help alleviate pain. Additionally, menthol has been shown to have antispasmodic effects on smooth muscle, which may contribute to its use in digestive disorders.

Pharmacodynamics

The pharmacodynamic properties of mentha are attributed to its active constituents, particularly menthol. It exhibits analgesic, anti-inflammatory, and antispasmodic effects. The cooling sensation produced by menthol can also trigger the release of endorphins, which may enhance its analgesic properties. Furthermore, menthol can increase local blood flow, which aids in the relief of muscle tension and pain.

Pharmacokinetics

Mentha's pharmacokinetics can vary based on the method of administration (oral, topical, or inhalation). When ingested, menthol is rapidly absorbed in the gastrointestinal tract and metabolized in the liver. Peak plasma concentrations are usually achieved within 30 to 60 minutes. The elimination half-life of menthol is approximately 2 to 4 hours. Topically applied menthol may provide localized effects with minimal systemic absorption, reducing the risk of systemic side effects.

Adverse effects

• Allergic reactions
• Heartburn
• Nausea
• Vomiting
• Skin irritation

Interactions

• May interact with anticoagulants
• May affect the absorption of certain medications due to its effects on gastrointestinal motility

Precautions

• Use with caution in individuals with gastroesophageal reflux disease (GERD)
• Caution in patients with liver disease
• Avoid use in infants and young children due to potential respiratory issues

Pregnancy

Mentha is generally considered safe in food amounts, but high doses should be avoided due to potential effects on uterine contractions.

Breast-feeding

Mentha is likely safe in food amounts during breastfeeding, but high doses should be avoided due to potential effects on milk supply and infant health.

Storage

Store in a cool, dry place away from direct sunlight.

Formulations

• Essential oil
• Tea
• Extracts
• Capsules

Indications

• Wound healing
• Oral health (e.g., gingivitis, mouth ulcers)
• Anti-inflammatory conditions
• Gastrointestinal disorders (e.g., dyspepsia)
• Antimicrobial applications

Dosage

Children: Refer to established herbal guidelines as specific dosing information may vary based on preparation and condition being treated.

Adults: Refer to established herbal guidelines as specific dosing information may vary based on preparation and condition being treated.

Mechanism of action

The active compounds in officinale, such as resins and essential oils, exhibit their effects through various mechanisms, including the inhibition of pro-inflammatory cytokines and modulation of immune responses. These actions contribute to its analgesic and antimicrobial properties, making it beneficial in treating wounds and oral infections.

Pharmacodynamics

Myrrh has demonstrated a range of pharmacodynamic effects, including analgesia, anti-inflammatory activity, and antimicrobial action. The resin contains various terpenoids and phenolic compounds, which interact with biological pathways to exert these effects. Studies suggest that myrrh may inhibit the growth of certain bacteria and fungi, as well as reduce inflammation by blocking the synthesis of pro-inflammatory mediators.

Pharmacokinetics

The pharmacokinetics of myrrh are not well-defined due to variability in preparation and formulation. However, it is generally believed that the compounds are absorbed through the gastrointestinal tract when ingested, with some components potentially being metabolized in the liver. The onset of action may vary depending on the method of administration, with topical applications likely providing localized effects.

Pregnancy

Safety during pregnancy has not been established; consult a healthcare provider before use.

Breast-feeding

Consult a healthcare provider before using, as safety during breastfeeding is not well established.

Storage

Store in a cool, dry place away from direct sunlight.

Indications

• Allergic rhinitis
• Urticaria
• Allergic conjunctivitis
• Anaphylactic reactions (as adjunctive therapy)

Dosage

Children: Refer to the specific prescribing information or guidelines for paediatric dosing.

Adults: Refer to the specific prescribing information or guidelines for adult dosing.

Mechanism of action

Piperata acts as a competitive antagonist of histamine at the H1 receptor. By binding to these receptors, it prevents histamine from exerting its effects, which include vasodilation, increased vascular permeability, and stimulation of sensory nerves. This mechanism is crucial in mitigating the physiological responses associated with allergic reactions.

Pharmacodynamics

The pharmacodynamic effects of piperata include the reduction of allergic symptoms through its antihistaminic properties. It also exhibits anticholinergic activity, which can contribute to its efficacy in reducing secretions and causing sedation. The onset of action typically occurs within 1 to 2 hours after administration, and the duration of action can last several hours, depending on the formulation and individual patient factors.

Pharmacokinetics

Piperata is well-absorbed from the gastrointestinal tract, with peak plasma concentrations occurring within 1 to 2 hours post-ingestion. It is metabolized primarily in the liver through cytochrome P450 enzymes, and its metabolites are excreted primarily via the urine. The elimination half-life is generally around 6 to 12 hours, although this can vary based on patient-specific factors, including age and liver function.

Pregnancy

Piperata is generally not recommended during pregnancy due to potential risks to the fetus and lack of sufficient safety data.

Breast-feeding

Piperata is not advised during breastfeeding as it may be excreted in breast milk and could affect the nursing infant.

Storage

Store in a cool, dry place, away from direct sunlight. Keep out of reach of children.

Indications

• Gastrointestinal disorders
• Respiratory issues
• Skin ailments
• Antioxidant support
• Anti-inflammatory conditions

Dosage

Children: Dosage varies based on the specific preparation and indication. Refer to professional herbal sources for guidance.

Adults: Dosage varies based on the specific preparation and indication. Refer to professional herbal sources for guidance.

Mechanism of action

The exact mechanism of action of Terminalia species is not fully understood; however, it is believed that they exert their effects through multiple pathways. The phytochemicals present, such as tannins, flavonoids, and phenolic compounds, may contribute to their antioxidant activity, which helps in scavenging free radicals and reducing oxidative stress. Additionally, anti-inflammatory effects may be mediated through the inhibition of pro-inflammatory cytokines and enzymes.

Pharmacodynamics

Terminalia extracts demonstrate a range of pharmacodynamic effects, including antioxidant, anti-inflammatory, antimicrobial, and hepatoprotective properties. These effects are primarily attributed to the presence of bioactive compounds that modulate various biochemical pathways in the body. For instance, the anti-inflammatory properties can lead to a reduction in swelling and pain, while antioxidant effects may protect cells from damage.

Pharmacokinetics

The pharmacokinetics of Terminalia extracts are not well characterized due to the variability in composition among different species and preparations. Generally, the bioavailability of herbal compounds can be influenced by various factors, including the method of extraction, formulation, and route of administration. Metabolism may occur in the liver, and the elimination of active compounds typically involves renal excretion.

Pregnancy

There is insufficient reliable information regarding the safety of Terminalia during pregnancy. Caution is advised.

Breast-feeding

Limited data is available on the excretion of Terminalia in breast milk. Caution should be exercised.

Storage

Store in a cool, dry place away from direct sunlight. Keep out of reach of children.

Indications

• Nausea and vomiting associated with motion sickness
• Nausea in pregnancy (morning sickness)
• Post-operative nausea and vomiting
• Osteoarthritis and other inflammatory joint conditions
• Dyspepsia and gastrointestinal discomfort

Dosage

Children: Refer to established guidelines and consult a healthcare professional for appropriate dosing based on formulation and indication.

Adults: Refer to established guidelines and consult a healthcare professional for appropriate dosing based on formulation and indication.

Mechanism of action

Ginger contains bioactive compounds, including gingerol and shogaol, which exhibit anti-inflammatory and antioxidant effects. The mechanism of action involves the inhibition of pro-inflammatory cytokines and enzymes, such as cyclooxygenase and lipoxygenase, leading to reduced inflammation. Ginger also enhances gastrointestinal motility and may exert a protective effect on the gastric mucosa.

Pharmacodynamics

The pharmacodynamic effects of ginger are primarily attributed to its active constituents, which modulate various physiological pathways. Gingerol and shogaol have been shown to influence the release of serotonin and other neurotransmitters, thereby alleviating nausea. Additionally, ginger's antioxidant properties help to mitigate oxidative stress in cells, contributing to its anti-inflammatory effects.

Pharmacokinetics

Ginger is rapidly absorbed in the gastrointestinal tract, with peak plasma concentrations of its active compounds occurring within 1-2 hours after ingestion. The bioavailability of gingerol and shogaol can be affected by the formulation and method of preparation (e.g., fresh, dried, or as an extract). The elimination half-life of these compounds is variable, with metabolism occurring primarily in the liver. They are excreted through urine and bile, and their effects can last for several hours.

Adverse effects

• Gastrointestinal discomfort
• Heartburn
• Nausea
• Diarrhea
• Skin irritation

Interactions

• Anticoagulants (e.g., warfarin)
• Antidiabetic medications
• Antihypertensive medications

Precautions

• Use with caution in patients with gallstones
• May affect blood sugar levels; monitor in diabetic patients
• May increase the risk of bleeding when used with anticoagulants

Pregnancy

Zingiber (ginger) is generally considered safe in food amounts during pregnancy. However, high doses should be avoided due to potential risks.

Breast-feeding

Zingiber is likely safe in food amounts while breastfeeding, but high doses should be avoided.

Storage

Store in a cool, dry place, away from direct sunlight.

Formulations

• Dried root
• Powder
• Capsules
• Tinctures
• Essential oil

Mechanism of action

Curcumin acts as a scavenger of oxygen species, such as hydroxyl radical, superoxide anion, and singlet oxygen and inhibit lipid peroxidation as well as peroxide-induced DNA damage. Curcumin mediates potent anti-inflammatory agent and anti-carcinogenic actions via modulating various signalling molecules. It suppresses a number of key elements in cellular signal transduction pathways pertinent to growth, differentiation, and malignant transformation; it was demonstrated _in vitro_ that curcumin inhibits protein kinases, c-Jun/AP-1 activation, prostaglandin biosynthesis, and the activity and expression of the enzyme cyclooxygenase (COX)-2. Curcumin, a polyphenolic natural product, exhibits therapeutic activity against a number of diseases, attributed mainly to its chemical structure and unique physical, chemical, and biological properties. It is a diferuloyl methane molecule [1,7-bis (4-hydroxy-3- methoxyphenyl)-1,6-heptadiene-3,5-dione)] containing two ferulic acid residues joined by a methylene bridge. It has three important functionalities: an aromatic o-methoxy phenolic group, alpha, beta-unsaturated beta-diketo moiety and a seven carbon linker. Extensive research in the last two decades has provided evidence for the role of these different functional groups in its crucial biological activities. A few highlights of chemical structural features associated with the biological activity of curcumin are: The o-methoxyphenol group and methylenic hydrogen are responsible for the antioxidant activity of curcumin, and curcumin donates an electron/ hydrogen atom to reactive oxygen species. Curcumin interacts with a number of biomolecules through non-covalent and covalent binding. The hydrogen bonding and hydrophobicity of curcumin, arising from the aromatic and tautomeric structures along with the flexibility of the linker group are responsible for the non-covalent interactions. The alpha, beta-unsaturated beta-diketone moiety covalently interacts with protein thiols, through Michael reaction. The beta-diketo group forms chelates with transition metals, thereby reducing the metal induced toxicity and some of the metal complexes exhibit improved antioxidant activity as enzyme mimics. New analogues with improved activity are being developed with modifications on specific functional groups of curcumin... The present study demonstrates that curcumin acts as pro-oxidant and sensitizes human lung adenocarcinoma epithelial cells (A549) to apoptosis via intracellular redox status mediated pathway. Results indicated that curcumin induced cell toxicity (light microscopy and MTT assay) and apoptosis (AnnexinV-FITC/PI labeling and caspase-3 activity) in these cells. These events seem to be mediated through generation of reactive oxygen species (ROS) and superoxide radicals (SOR) and enhanced levels of lipid peroxidation. These changes were accompanied by increase in oxidized glutathione (GSSG), reduced glutathione (GSH) and gamma-glutamylcysteine synthetase (gamma-GCS) activity, but decrease in GSH/GSSG ratio. The induction of apoptosis and decrease in GSH/GSSG ratio was also accompanied by sustained phosphorylation and activation of p38 mitogen activated protein kinase (MAPK). On the other hand, addition of N-acetyl cysteine (NAC), an antioxidant, blocked the curcumin-induced ROS production and rescued malignant cells from curcumin-induced apoptosis through caspase-3 deactivation. However, L-buthionine sulfoximine (BSO), a GSH synthesis blocking agent, further enhanced curcumin-induced ROS production and apoptosis in A549 cells. Decreased GSH/GSSG ratio seems to be a crucial factor for the activation of MAPK signaling cascade by curcumin. The study therefore, provides an insight into the molecular mechanism involved in sensitization of lung adenocarcinoma cells to apoptosis by curcumin. Curcumin has many pharmaceutical applications, many of which arise from its potent antioxidant properties. The present research examined the antioxidant activiti

Pharmacodynamics

Intravenous application of 25 mg/kg bw curcumin to rats resulted in an increase in bile flow by 80 and 120%. In the rat model of inflammation, curcumin was shown to inhibit edema formation. In nude mouse that had been injected subcutaneously with prostate cancer cells, administration of curcumin caused a marked decrease in the extent of cell proliferation, a significant increase of apoptosis and micro-vessel density. Curcumin may exert choleretic effects by increasing biliary excretion of bile salts, cholesterol, and bilirubin, as well as increasing bile solubility. Curcumin inhibited arachidonic acid-induced platelet aggregation _in vitro_.